Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus

We have evaluated the potential of two peptides derived from highly conserved regions of rotavirus outer capsid proteins (VP7 and VP4) to act as a rotavirus vaccine. The capacity of peptides coupled to rotavirus VP6 spherical particles to provide passive protection in a murine model was compared with the protection induced by peptide-keyhole limpet hemocyanin (KLH) conjugates. Female mice were immunized a total of three times before and during pregnancy. Suckling mouse pups were challenged at 7 days of age with either homologous or heterologous rotavirus serotypes. The efficacy of vaccination was determined by analyzing the clinical symptoms and measuring xylose adsorption in the intestine. In this model the VP4 peptide-VP6 conjugate provided protection equal to that obtained using bovine rotavirus (BRV) as the immunogen. The VP7 peptide-VP6 conjugate provided slightly less protection than the VP4 peptide-VP6 conjugate. A mixture of the VP4 peptide-VP6 and VP7 peptide-VP6 conjugates provided better heterologous protection than immunization with BRV. In contrast, KLH-conjugated peptides provided only partial protection. The significance of a synthetic-peptide-based rotavirus vaccine in the prevention of rotavirus infections is discussed.

[1]  P. Offit,et al.  Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice , 1990, Journal of virology.

[2]  H. Greenberg,et al.  Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes , 1990, Journal of virology.

[3]  S. Michalek,et al.  Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces , 1990, Infection and immunity.

[4]  M. Sabara,et al.  Development of a rotavirus plaque assay using Sephadex G-75. , 1990, Journal of virological methods.

[5]  H. Greenberg,et al.  Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge , 1990, Journal of virology.

[6]  W. Chiu,et al.  Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy , 1990, Nature.

[7]  M. Estes,et al.  Rotavirus gene structure and function. , 1989, Microbiological reviews.

[8]  P. Artursson,et al.  Microparticles as potentially orally active immunological adjuvants. , 1989, Vaccine.

[9]  D. Haines,et al.  Development of a murine model to study the pathogenesis of rotavirus infection , 1989, Experimental and Molecular Pathology.

[10]  W. Schaaper,et al.  Manipulation of antipeptide immune response by varying the coupling of the peptide with the carrier protein. , 1989, Molecular immunology.

[11]  J. Eldridge,et al.  Biodegradable microspheres: vaccine delivery system for oral immunization. , 1989, Current topics in microbiology and immunology.

[12]  R. Glass,et al.  Diarrheal deaths in American children. Are they preventable? , 1988, JAMA.

[13]  R. S. Roy,et al.  Immune response of pregnant heifers and cows to bovine rotavirus inoculation and passive protection to rotavirus infection in newborn calves fed colostral antibodies or colostral lymphocytes. , 1988, American journal of veterinary research.

[14]  O. Yoshie,et al.  Role of VP3 in human rotavirus internalization after target cell attachment via VP7 , 1988, Journal of virology.

[15]  R. Chanock,et al.  Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus , 1988, Journal of virology.

[16]  R. Wirtz,et al.  Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides. , 1988, Science.

[17]  R. Ward,et al.  Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus , 1988, Journal of virology.

[18]  B. Morein,et al.  The iscom antigen-presenting system , 1988, Nature.

[19]  H. Greenberg,et al.  The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Babiuk,et al.  Immune Responses to Synthetic Peptide Vaccines of Veterinary Importance , 1988 .

[21]  L. Babiuk,et al.  Assessment of intestinal damage in rotavirus infected neonatal mice by a d-xylose absorption test , 1987, Journal of Virological Methods.

[22]  R. Yolken,et al.  Epitope-specific immune responses to rotavirus vaccination. , 1987, Gastroenterology.

[23]  J. Bridger,et al.  Avirulent rotavirus infections protect calves from disease with and without inducing high levels of neutralizing antibody. , 1987, The Journal of general virology.

[24]  R. F. Ramig,et al.  Protection between different serotypes of bovine rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responses , 1987, Journal of clinical microbiology.

[25]  L. Babiuk,et al.  The complete nucleotide sequence of bovine rotavirus C486 gene 4 cDNA. , 1987, Nucleic acids research.

[26]  M. Estes,et al.  Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system , 1987, Journal of virology.

[27]  M. Sabara,et al.  In vitro assembly of bovine rotavirus nucleocapsid protein. , 1987, Virology.

[28]  M. Lizano,et al.  Synthesis in Escherichia coli and immunological characterization of a polypeptide containing the cleavage sites associated with trypsin enhancement of rotavirus SA11 infectivity. , 1987, The Journal of general virology.

[29]  M. Summers,et al.  A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. , 1987 .

[30]  P. Frenchick,et al.  Biochemical evidence for the oligomeric arrangement of bovine rotavirus nucleocapsid protein and its possible significance in the immunogenicity of this protein. , 1987, The Journal of general virology.

[31]  T. Dyrberg,et al.  Peptides as antigens. Importance of orientation , 1986, The Journal of experimental medicine.

[32]  R. M. Khaitov,et al.  Influenza virus antigens conjugated with a synthetic polyelectrolyte: a novel model of vaccines. , 1985, Vaccine.

[33]  C. Leclerc,et al.  Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. , 1985, Journal of immunology.

[34]  A. Bellamy,et al.  Rotavirus neutralizing protein VP7: antigenic determinants investigated by sequence analysis and peptide synthesis , 1985, Journal of virology.

[35]  M. Sabara,et al.  Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein , 1985, Journal of virology.

[36]  B. Roizman,et al.  Application of Denatured, Electrophoretically Separated, and Immobilized Lysates of Herpes Simplex Virus-Infected Cells for Detection of Monoclonal Antibodies and for Studies of the Properties of Viral Proteins , 1983, Journal of virology.

[37]  S. Inouye,et al.  Purification of an outer capsid glycoprotein of neonatal calf diarrhea virus and preparation of its antisera , 1983, Infection and immunity.

[38]  Richard A. Lerner,et al.  Immunogenic structure of the influenza virus hemagglutinin , 1982, Cell.

[39]  Leonore A. Herzenberg,et al.  Carrier-priming leads to hapten-specific suppression , 1980, Nature.

[40]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[41]  L. Babiuk,et al.  Rotavirus isolation and cultivation in the presence of trypsin , 1977, Journal of clinical microbiology.

[42]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.